Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.

The Journal of thoracic and cardiovascular surgery - 1 Mar 2002

Ahrendt Steven A, Yang Stephen C, Wu Li, Roig Carmen M, Russell Pamela, Westra William H, Jen Jin, Brock Malcolm V, Heitmiller Richard F, Sidransky David

Abstract excerpt

OBJECTIVES: Routine histologic examination of resected lymph nodes in patients with stage I non-small cell lung cancer may underestimate the incidence of advanced disease. The presence of occult lymph node metastases may predict a higher risk of recurrence after intended curative resection. The purpose of this study was to determine the prognostic significance of TP53 and K-ras mutations in histologically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Genes, p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Lung Neoplasms

Share to Lymph Nodes

Share to Lymphatic Metastasis

Share to Neoplasm Staging

Share to Survival Analysis

Source

Identifiers

PMID: 11882817
DOI: 10.1067/mtc.2002.120343

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.PMID 11882817Read ↗

Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.Semantic proximity Read ↗

Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers.Semantic proximity Read ↗

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.Semantic proximity Read ↗

Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension.Semantic proximity Read ↗

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.Semantic proximity Read ↗

Expression profiling of non-small cell lung carcinoma identifies metastatic genotypes based on lymph node tumor burden.Semantic proximity Read ↗

Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer.Semantic proximity Read ↗

p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.Semantic proximity Read ↗

Genomic Profiles as Predictors of Occult Lymph Node Metastasis and Clinical Outcomes in Early-Stage Clinical N0 Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma.Semantic proximity Read ↗

Do molecular markers predict survival in non-small-cell lung cancer?Semantic proximity Read ↗

Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.